Skip to content

Anxiety: all studies

Page 15 of 772: studies 141 to 150 of 7,715, newest first. Back to the anxiety overview

Research

Using a Virtual Reality CAVE-Based Mindfulness Intervention to Promote Mental Well-Being in Adolescents With Anxiety Symptoms: Pre-Post Mixed Methods Pilot Study.

JMIR Formative Research June 12, 2026 Clare Tsz Kiu Yu, Alex Pak Lik Tsang, Kelly Ka Yu Chan et al.

Adolescent anxiety is a growing public health concern associated with significant social and emotional impairment. Mindfulness-based interventions (MBIs) have shown promise in reducing anxiety and improving well-being; however, engagement remains challenging. Virtual reality (VR)-based delivery may enhance immersion and attention, potentially addressing barriers of traditional mindfulness...

Telehealth-supported ketamine for depression and anxiety: A systematic review.

Australasian Psychiatry June 11, 2026 Eden Mane, Saras Mane

ObjectivesTo systematically review the effectiveness, safety, and care models of telehealth-supported ketamine for depression and/or anxiety in adults and consider implications for Australasian clinical practice.MethodsFollowing PRISMA 2020, we searched for randomised or observational studies of adults receiving at-home telehealth-supported ketamine for depression and/or anxiety, to August...

Emotional body odors alter autonomic nervous activity during mindfulness training in social anxiety.

Journal of Anxiety Disorders June 10, 2026 Elisa Dal Bò, Cinzia Cecchetto, Letizia Zurlo et al.

Chemosignals found in human body odors (BOs) convey information about a person's emotional state and elicit observable responses in others. While mindfulness typically enhances parasympathetic tone and reduces anxiety, little is known about how BOs modulate these effects. This study investigated how emotional and non-emotional human BOs influence autonomic nervous system activity - heart rate...

Aquahenosis: A non-pharmacological altered state of consciousness induced by Floatation-REST in individuals with anxiety and depression

PsyArXiv June 10, 2026 Theo Tobel, Aidan Cone, Emily Choquette et al. preprint

Floatation-REST (Reduced Environmental Stimulation Therapy) systematically alters sensory and bodily input by combining neutral buoyancy, thermal and proprioceptive neutrality, attenuation of exteroceptive stimulation, and enhancement of cardiorespiratory signaling to the brain. Here we examined whether this non-pharmacological sensory perturbation induces altered states of consciousness and...

DOI: 10.31234/osf.io/6mj8n_v2 (opens in new tab) Altered state Perception Arousal Cardiorespiratory fitness +11

Beyond symptom change: a qualitative descriptive study of reported quality of life experiences among adults prescribed medicinal cannabis for anxiety disorders

International Journal of Clinical Pharmacy June 9, 2026 Leah Roberts, Craig Cumming, C. Budgeon et al.

Anxiety disorders are among the most prevalent and disabling mental health conditions and are associated with impairments in quality of life (QoL). Previous studies have examined medicinal cannabis for anxiety and QoL using short-term follow-up or cross-sectional surveys. However, there is little longitudinal qualitative research examining how patients experience QoL changes. To explore the...

Effectiveness of mindfulness-based cognitive therapy and virtual reality-based worry exposure therapy on cognitive avoidance and emotional capital in adolescents with social anxiety

Preventing School Failure: Alternative Education for Children and Youth June 4, 2026 Solmaz Choheili, F. Marashian, Sahar Safarzadeh et al.

Abstract This quasi-experimental study investigated the effectiveness of mindfulness-based cognitive therapy (MBCT) and virtual reality-based worry exposure therapy (VR-WET) on cognitive avoidance and emotional capital in adolescents with social anxiety. In Ahvaz, Iran, 60 adolescents aged 12–18 years were randomly assigned to MBCT (n = 20), VR-WET (n = 20), or a no-treatment control group (n =...

MDMA-Assisted Therapy for Social Anxiety Disorder: A Randomized, Open-label, Wait-list Controlled Trial

June 4, 2026 Jason B. Luoma, M. Kati Lear, Brian Pilecki et al. preprint

Background: ±3,4-methylenedioxymethamphetamine (MDMA) has positive effects on socio-emotional processing and MDMA-Assisted Therapy (MDMA-AT) showed promise for treating SAD in a previous placebo-controlled trial. Aims: Develop a preliminary estimate of clinical response and safety for MDMA-AT versus waitlist in adults with SAD. Secondary aims included refinement of a standardized psychotherapy...

DOI: 10.31234/osf.io/a9x6d_v1 (opens in new tab) Social anxiety Randomized controlled trial Adverse effect Clinical trial +3

Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depression.

Journal of Affective Disorders June 4, 2026 Carlton M Kelly, Mathieu Fradet, Catherine Bostian et al.

Psilocybin has demonstrated promise for improving depressive symptoms in treatment-resistant depression, but its effects on anxiety, quality of life, functioning, and posttraumatic stress symptoms are less well studied. This study reports exploratory findings from an open-label trial in Veterans with TRD. Participants received a single 25-mg dose of psilocybin administered with psychological...

Novel 5,6-Bicyclic Compounds as 5-HT2A Receptor Agonists for Treating Depression, Anxiety, Substance Abuse, and Headaches

ACS Medicinal Chemistry Letters June 3, 2026 Ram W. Sabnis, Anika R. Sabnis

Provided herein are novel 5,6-bicyclic compounds as 5-HT2A receptor agonists, pharmaceutical compositions, use of such compounds in treating depression, anxiety, substance abuse and headaches, and processes for preparing such compounds.